The Numbers

Orthopedic Market Report

Orthopedic Market Size and Share

Global orthopedic sales totaled $59 billion in 2023, an increase of 6.5% compared to 2022. Read our regularly updated analysis of the orthopedic market, including sales forecasts for all segments, company revenue and insight into key trends.

According to our estimates, just under 50 companies accounted for more than 85% of all orthopedic revenue in 2023.

Orthopedics’ Top Tier to Expand in 2024

According to our estimates, just under 50 companies accounted for more than 85% of all orthopedic revenue in 2023.

Funding announcements came from familiar names and supported well-backed markets like spine and enabling technology.

10 Orthopedic Companies Close New Funding Rounds in 1Q24

Funding announcements came from familiar names and supported well-backed markets like spine and enabling technology.

Orthopedic Companies Report Results for First Quarter 2024

Stay up to date on the orthopedic market’s 1Q performance in 2024 as we update this post with company sales data and industry developments.

,
Paragon 28 Takes Sequential Step Up in Record Quarter

The company grew more than 17% in the first quarter of 2024 despite a difficult comparison and one less selling day.

,
Treace Medical Reduces 2024 Guide on Competitive Headwinds

The company grew more than 20% in the first quarter of 2024 but lowered its full-year guidance due to increase competitive headwinds.

,
ATEC Sees Market Disruption As Long Tail Growth Driver

The company grew 27% in the first quarter of 2024 as it further capitalized on disruption in the spine market.

,
Bioventus Opens 2024 With Strong Growth Across Biologics Businesses

The company drove strong results for its non-surgical hyaluronic acid pain treatments and surgical bone graft substitutes.

,
Enovis on Track for $1 Billion Recon Business

Enovis’ reconstructive segment accounted for just 22% of sales in 2019. It will account for nearly 50% as it reaches $1 billion in 2024.

,
OrthoPediatrics Reports Improving Surgical Environment

The company’s orthopedic sales grew more than 22% in 1Q24 as volume and staffing improve in the pediatric market.

,
Anika Therapeutics Reiterates 2024 Guide, Cuts Costs

The company’s orthopedic sales grew in the mid-single-digits during 1Q24 as the company reduced headcount to control costs.

,
Vericel Keeps Momentum Ahead of MACI Arthro Launch

The company’s MACI sales grew nearly 18% in the first quarter of 2024 with the launch of MACI Arthro expected in the third quarter.

,
Orthopedic Companies Report Results for First Quarter 2024

Stay up to date on the orthopedic market’s 1Q performance in 2024 as we update this post with company sales data and industry developments.

,
Paragon 28 Takes Sequential Step Up in Record Quarter

The company grew more than 17% in the first quarter of 2024 despite a difficult comparison and one less selling day.

,
Treace Medical Reduces 2024 Guide on Competitive Headwinds

The company grew more than 20% in the first quarter of 2024 but lowered its full-year guidance due to increase competitive headwinds.

,
ATEC Sees Market Disruption As Long Tail Growth Driver

The company grew 27% in the first quarter of 2024 as it further capitalized on disruption in the spine market.

,
Bioventus Opens 2024 With Strong Growth Across Biologics Businesses

The company drove strong results for its non-surgical hyaluronic acid pain treatments and surgical bone graft substitutes.

,
Orthofix Medical Delivering on Key Priorities to Start 2024

The company grew in the high single digits for the first quarter of 2024, including above-market growth in the United States.

,

Contact Us

0